GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IRIDEX Corp (NAS:IRIX) » Definitions » Cyclically Adjusted PB Ratio

IRIDEX (IRIDEX) Cyclically Adjusted PB Ratio : 1.08 (As of Apr. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is IRIDEX Cyclically Adjusted PB Ratio?

As of today (2024-04-27), IRIDEX's current share price is $2.87. IRIDEX's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $2.66. IRIDEX's Cyclically Adjusted PB Ratio for today is 1.08.

The historical rank and industry rank for IRIDEX's Cyclically Adjusted PB Ratio or its related term are showing as below:

IRIX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.48   Med: 2.2   Max: 5.78
Current: 1.11

During the past years, IRIDEX's highest Cyclically Adjusted PB Ratio was 5.78. The lowest was 0.48. And the median was 2.20.

IRIX's Cyclically Adjusted PB Ratio is ranked better than
71.71% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs IRIX: 1.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

IRIDEX's adjusted book value per share data for the three months ended in Dec. 2023 was $0.586. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.66 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


IRIDEX Cyclically Adjusted PB Ratio Historical Data

The historical data trend for IRIDEX's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IRIDEX Cyclically Adjusted PB Ratio Chart

IRIDEX Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.90 2.13 0.71 1.06

IRIDEX Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.72 0.78 0.93 1.06

Competitive Comparison of IRIDEX's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, IRIDEX's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IRIDEX's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IRIDEX's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where IRIDEX's Cyclically Adjusted PB Ratio falls into.



IRIDEX Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

IRIDEX's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.87/2.66
=1.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IRIDEX's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, IRIDEX's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.586/129.4194*129.4194
=0.586

Current CPI (Dec. 2023) = 129.4194.

IRIDEX Quarterly Data

Book Value per Share CPI Adj_Book
201403 2.662 99.695 3.456
201406 2.602 100.560 3.349
201409 2.604 100.428 3.356
201412 3.447 99.070 4.503
201503 3.392 99.621 4.407
201506 3.317 100.684 4.264
201509 3.302 100.392 4.257
201512 3.366 99.792 4.365
201603 3.398 100.470 4.377
201606 3.412 101.688 4.342
201609 3.405 101.861 4.326
201612 3.464 101.863 4.401
201703 3.452 102.862 4.343
201706 3.252 103.349 4.072
201709 3.031 104.136 3.767
201712 2.632 104.011 3.275
201803 2.342 105.290 2.879
201806 2.095 106.317 2.550
201809 2.399 106.507 2.915
201812 2.203 105.998 2.690
201903 2.013 107.251 2.429
201906 1.864 108.070 2.232
201909 1.741 108.329 2.080
201912 1.647 108.420 1.966
202003 1.534 108.902 1.823
202006 1.356 108.767 1.613
202009 1.241 109.815 1.463
202012 1.249 109.897 1.471
202103 1.652 111.754 1.913
202106 1.705 114.631 1.925
202109 1.596 115.734 1.785
202112 1.468 117.630 1.615
202203 1.342 121.301 1.432
202206 1.218 125.017 1.261
202209 1.130 125.227 1.168
202212 1.078 125.222 1.114
202303 0.992 127.348 1.008
202306 0.830 128.729 0.834
202309 0.743 129.860 0.740
202312 0.586 129.419 0.586

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IRIDEX  (NAS:IRIX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


IRIDEX Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of IRIDEX's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IRIDEX (IRIDEX) Business Description

Traded in Other Exchanges
N/A
Address
1212 Terra Bella Avenue, Mountain View, CA, USA, 94043
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
Executives
Nandini Devi director 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Beverly A Huss director C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Robert Earle Grove director 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Topcon Corp 10 percent owner 75-1, HASUNUMA-CHO, ITABASHI-KU, TOKYO M0 174-8580
Topcon America Corp 10 percent owner 111 BAUER DRIVE, OAKLAND NJ 07426
Fuad Ahmad officer: Interim CFO 461 SOUTH MILPITAS BLVD., MILPITAS CA 95035
Doris Engibous director C/O NATUS MEDICAL INCORPORATED, 1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Scott Shuda director 402 RAILROAD AVENUE, SUITE 201, DANVILLE CA 94526
Patrick Mercer officer: COO 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Ruediger Naumann-etienne director
Robert A Gunst director
David Bruce director, officer: President and CEO 1178 GLEN ROAD, LAFAYETTE CA 94549
Ken Ludlum director
Romeo R Dizon other: Vice President and Controller 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043